{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:51:43Z","timestamp":1786992703163,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["765394"],"award-info":[{"award-number":["765394"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jim.2021.113173","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T07:23:32Z","timestamp":1635146612000},"page":"113173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies"],"prefix":"10.1016","volume":"499","author":[{"given":"Aina","family":"Segu\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander M.J.","family":"van Duijnhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Parade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nata\u0161a","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Zaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.A.M.","family":"Sijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"van Elsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2021.113173_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nn738","article-title":"TNF\u03b1 promotes proliferation of oligodendrocyte progenitors and remyelination","author":"Arnett","year":"2001","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jim.2021.113173_bb0010","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1807499115","article-title":"Intrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunity","author":"Atretkhany","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2021.113173_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(93)90132-A","article-title":"Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation","author":"Banner","year":"1993","journal-title":"Cell."},{"key":"10.1016\/j.jim.2021.113173_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01740-5","article-title":"TNF\u03b1\/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function","author":"Beldi","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jim.2021.113173_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: live or let die","author":"Brenner","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.04.023","article-title":"Cell co-receptors for cancer therapy","author":"Callahan","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jim.2021.113173_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI32567","article-title":"TNF-\u03b1 is critical for antitumor but not antiviral T cell immunity in mice","author":"Calzascia","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jim.2021.113173_bb0040","article-title":"Co-expression of TNFR2 and CD25 identifies more of the functional CD4 + FOXP3 + regulatory T cells in human peripheral blood: immunomodulation","author":"Chen","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133647","article-title":"Differentiated agonistic antibody targeting CD137 eradicates large tumors without hepatotoxicity","author":"Eskiocak","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jim.2021.113173_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00401","article-title":"Selective targeting of TNF receptors as a novel therapeutic approach","author":"Fischer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jim.2021.113173_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/bs.pmbts.2019.03.010","article-title":"TNFR2-expressing CD4+Foxp3+ regulatory T cells in cancer immunology and immunotherapy","author":"He","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jim.2021.113173_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.11.102","article-title":"TNFR2 signaling enhances ILC2 survival, function, and induction of airway Hyperreactivity","author":"Hurrell","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jim.2021.113173_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.99.11.1492","article-title":"Tissue expression and immunolocalization of tumor necrosis factor-\u03b1 in postinfarction dysfunctional myocardium","author":"Irwin","year":"1999","journal-title":"Circulation."},{"key":"10.1016\/j.jim.2021.113173_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589380","article-title":"T-cell hyperactivation and paralysis in severe COVID-19 infection revealed by single-cell analysis","author":"Kalfaoglu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0075","article-title":"TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth","author":"Kim","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/ng.557","article-title":"From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis","author":"Lincecum","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jim.2021.113173_bb0085","article-title":"BAFF inhibition: a new class of drugs for the treatment of autoimmunity","author":"Liu","year":"2011","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jim.2021.113173_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.jim.2021.113173_bb0095","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0211-16.2016","article-title":"Oligodendroglial TNFR2 mediates membrane TNF-dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination","author":"Madsen","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jim.2021.113173_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2018.75","article-title":"The promise and challenges of immune agonist antibody development in cancer","author":"Mayes","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jim.2021.113173_bb0105","doi-asserted-by":"crossref","DOI":"10.1080\/14728222.2019.1586886","article-title":"Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target","author":"Medler","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jim.2021.113173_bb0110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.082107699","article-title":"CD40 stimulation leads to effective therapy of CD40- tumors through induction of strong systemic cytotoxic T lymphocyte immunity","author":"van Mierlo","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2021.113173_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000954","article-title":"Solution of the structure of the TNF-TNFR2 complex","author":"Mukai","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jim.2021.113173_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-00564-3","article-title":"The TNF\/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect","author":"Naserian","year":"2020","journal-title":"Cell Commun. Signal. CCS"},{"key":"10.1016\/j.jim.2021.113173_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-02057-z","article-title":"Regulatory T cell induction by mesenchymal stem cells depends on the expression of TNFR2 by T cells","author":"Naserian","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jim.2021.113173_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02306","article-title":"Immune checkpoints as therapeutic targets in autoimmunity","author":"Paluch","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-009-1267-1","article-title":"The inflammatory receptor CD40 is expressed on human adipocytes: contribution to crosstalk between lymphocytes and adipocytes","author":"Poggi","year":"2009","journal-title":"Diabetologia."},{"key":"10.1016\/j.jim.2021.113173_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Primer."},{"key":"10.1016\/j.jim.2021.113173_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014043118","article-title":"Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2\u2013expressing Treg cells","author":"Ronin","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jim.2021.113173_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.12.034","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","author":"Sade-Feldman","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jim.2021.113173_bb0155","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-13-0067","article-title":"Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer","author":"Sandin","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jim.2021.113173_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2006.02.007","article-title":"Expression of tumor necrosis factor alpha and its receptors during cellular differentiation","author":"Schling","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.jim.2021.113173_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00364","article-title":"Role of tumor necrosis factor superfamily in Neuroinflammation and autoimmunity","author":"Sonar","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/0022-1759(92)90090-G","article-title":"A new approach to the generation of human or murine antibody producing hybridomas","author":"Steenbakkers","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2021.113173_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/BF00997158","article-title":"Efficient generation of monoclonal antibodies from preselected antigenspecific B cells","author":"Steenbakkers","year":"1994","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jim.2021.113173_bb0180","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6066.CIR-17-0767","article-title":"Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) costimulation","author":"Teijeira","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jim.2021.113173_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0772-0","article-title":"Functional characterization of the selective pan-allele anti-SIRP\u03b1 antibody ADU-1805 that blocks the SIRP\u03b1\u2013CD47 innate immune checkpoint","author":"Voets","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jim.2021.113173_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.04.019","article-title":"The TNF receptor superfamily in co-stimulating and co-inhibitory responses","author":"Ward-Kavanagh","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.jim.2021.113173_bb0195","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.147.12.4229","article-title":"Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells","volume":"147","author":"Ware","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3","author":"Williams","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2021.113173_bb0205","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.11943","article-title":"Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy","author":"Williams","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jim.2021.113173_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2016.04.017","article-title":"Co-stimulatory and co-inhibitory pathways in autoimmunity","author":"Zhang","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.jim.2021.113173_bb0215","article-title":"Tumor necrosis factor receptor 2 promotes growth of colorectal cancer via the PI3K\/AKT signaling pathway","author":"Zhao","year":"2017","journal-title":"Oncol. Lett."}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921002180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175921002180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:27:24Z","timestamp":1762205244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175921002180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"alternative-id":["S0022175921002180"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2021.113173","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of novel co-stimulatory anti-mouse TNFR2 antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2021.113173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113173"}}